Inactive Instrument
Lipidor AB Stock Deutsche Boerse AG
Stocks
L7R
SE0012558617
Pharmaceuticals
OTC Markets Traded| 1 day | -50.34% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -50.34% | -59.44% | - | - | 92.63K | |
| -0.53% | -3.95% | +55.23% | +152.74% | 1,030B | |
| +0.21% | -2.68% | +55.61% | +53.02% | 617B | |
| -2.51% | -3.25% | +32.76% | +67.76% | 455B | |
| +0.06% | -0.42% | +37.53% | +30.67% | 350B | |
| -0.14% | -0.24% | +34.41% | +39.01% | 299B | |
| -0.69% | -0.30% | +11.55% | +12.93% | 265B | |
| -7.37% | -4.40% | -2.54% | -43.87% | 225B | |
| -0.64% | +2.43% | +30.52% | +64.49% | 209B | |
| -0.82% | +0.70% | +15.96% | +71.01% | 163B | |
| Average | -6.28% | +1.38% | +30.11% | +49.75% | 401.41B | |
| Weighted average by Cap. | -1.02% | -0.11% | +39.02% | +72.47% |
Employees
4
Sector
Pharmaceuticals
